Literature summary for 2.7.11.28 extracted from

Cranston, A.; Stocken, D.D.; Stamp, E.; Roblin, D.; Hamlin, J.; Langtry, J.; Plummer, R.; Ashworth, A.; Burn, J.; Rajan, N.
Tropomyosin receptor antagonism in cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours study protocol for a randomised controlled trial (2017), Trials, 18, 111 .

Inhibitors

Inhibitors	Comment	Organism	Structure
pegcantratinib	previously CT327	Homo sapiens

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Synonyms	Comment	Organism
TRK	-	Homo sapiens
tropomyosin receptor kinase	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)